Moolec Science (MLECW) Profit After Tax (2022 - 2024)
Moolec Science (MLECW) posted Profit After Tax of $153280.0 for Q4 2024, up 108.0% sequentially from -$1.9 million in Q3 2024, and up 117.36% YoY from $70518.4 in Q1 2024.
Moolec Science (MLECW) Profit After Tax (2022 - 2024) Analysis & Trends
Moolec Science has reported Profit After Tax for 3 years, with the latest figure at $153280.0 in Q4 2024.
- Quarterly Profit After Tax rose 117.36% year-over-year to $153280.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$5.7 million (down 2.14% YoY) and the FY2024 annual result came in at -$7.3 million, up 85.88% from the prior year.
- Profit After Tax climbed to $153280.0 in Q4 2024 per MLECW's latest filing, from -$1.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at $721426.0 in Q3 2022 and troughed at -$48.0 million in Q4 2022.
- A 3-year average of -$5.1 million and a median of -$1.5 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2023 and 2024: Profit After Tax plunged 320.54% in 2023, then surged 117.36% in 2024.
- Over 3 years, Profit After Tax stood at -$48.0 million in 2022, then soared by 98.16% to -$882861.0 in 2023, then soared by 117.36% to $153280.0 in 2024.
- According to Business Quant data, Profit After Tax over the past three periods registered $153280.0, -$1.9 million, and -$2.5 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 153,280.00 |
| Sep 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -2.54 Mn |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | -882,861.00 |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -2.75 Mn |
| Mar 31, 2023 | -358,578.00 |
| Dec 31, 2022 | -47.96 Mn |
| Sep 30, 2022 | 721,426.00 |
| Jun 30, 2022 | -1.52 Mn |
| Mar 31, 2022 | -1.17 Mn |